PharVision Advisers’s SLR Investment Corp SLRC Stock Holding History

PharVision Advisers’s Portfolio SLRC Stock Details SLRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,881	Closed	-$176K	–	783
2025 Q2	$176K	Buy	+10,881	New	+$174K	0.25%	217

Other funds holding SLRC

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Muzinich & Co New York $286M AUM 21.05% 1-Year Est. Return

PharVision Advisers's SLRC Position: Q3 2025 in Review

PharVision Advisers sold out of SLR Investment Corp (SLRC) in Q3 2025, closing a stake of 10,881 shares — an estimated $176K sold.

PharVision Advisers first reported a position in SLRC in Q2 2025 and held it in 1 quarter. The position peaked at $176K in Q2 2025. 117 funds tracked by Wall St. Rank hold SLRC as of Q3 2025.

PharVision Advisers reported no remaining SLR Investment Corp position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 10,881 SLR Investment Corp shares in Q3 2025, an estimated $176K.
PharVision Advisers first reported a position in SLR Investment Corp in Q2 2025 and held it in 1 quarter.
PharVision Advisers's SLR Investment Corp position peaked at $176K in Q2 2025.
117 funds tracked by Wall St. Rank held SLR Investment Corp as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.